Lonza supplies two highly effective antimicrobials to formulators of hygiene products and hand soaps seeking alternative active ingredients. Registered for use by the EPA, Lonza’s Hyamine 1622, is a benzethonium chloride antimicrobial that is approved for formulations in a variety of industrial or household sanitizers and disinfectants.
Lonzagard Benzethonium Chloride USP antimicrobials can be used as an active ingredient in numerous hygiene applications including non-alcohol hand sanitizers. It provides a short contact time against a large number of gram-positive and gram-negative bacterial organisms and is fully compatible with a wide variety of formulations as well as most types of cationic and nonionic systems. It has an excellent efficacy and safety profile as an antimicrobial ingredient. Scientific and regulatory reviews of ticlosan use are being conducted by the US Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA).
“Consumers are concerned about the recent studies that have prompted further FDA and EPA review of Triclosan,” says Ray Fahmy, Lonza’s North America Hygiene & Preservation Marketing Manager. “For formulators seeking Triclosan alternatives, we have two highly effective replacement products along with a team of strong regulatory, microbiological and analytical experts to support formulators.”
Triclosan is an antibacterial and antifungal agent used in a variety of consumer and industrial products including household bacterial soaps. The FDA has been conducting what it calls a “comprehensive scientific and regulatory review” of the available data for Triclosan, and it is expected to announce its findings soon. The EPA has reported that it is initiating its registration review process for Triclosan this year, ten years ahead of the original schedule. Furthermore, the EPA and the FDA are collaborating to determine if any changes in the current regulations for Triclosan are necessary.
Triclosan Alternatives Available from Lonza
Published August 2, 2013
blog comments powered by Disqus